Uric Acid, Cardiovascular Mortality, and Long-Term Outcomes in CKD

References 

1. Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009;53:796–803
   • Abstract
   • Full Text
   • Full-Text PDF (265 KB)
   • CrossRef
2. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009;53:596–605
   • Abstract
   • Full Text
   • Full-Text PDF (747 KB)
   • CrossRef
3. Zoccali C. The endothelium as a target in renal diseases. J Nephrol. 2007;20(suppl 12):S39–S44
4. Iwanami J, Mogi M, Iwai M, Horiuchi M. Inhibition of the renin-angiotensin system and target organ protection. Hypertens Res. 2009;32:229–237
   • CrossRef
5. Hamada T, Ichida K, Hosoyamada M, et al. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. Am J Hypertens. 2008;21:1157–1162
   • CrossRef
6. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994;331:1675–1679
   • MEDLINE
   • CrossRef